elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q49184931-60775C30-1584-445A-8ADB-F93611F46290
Q49184931-60775C30-1584-445A-8ADB-F93611F46290
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49184931-60775C30-1584-445A-8ADB-F93611F46290
Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors.
P2860
Q49184931-60775C30-1584-445A-8ADB-F93611F46290
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49184931-60775C30-1584-445A-8ADB-F93611F46290
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4838fa81a6be002f44bd61f850b1834a2a43bf4f
P2860
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.